{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:43:57Z","timestamp":1792183437064,"version":"4.4.0"},"reference-count":38,"publisher":"American Society of Hematology","issue":"14","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,23]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Adult T-cell leukemia\/lymphoma (ATL) is a poor prognosis hematological malignancy originating from human T-cell leukemia virus 1 (HTLV-1)\u2013infected CD4+ T cells. Flow cytometric plots of CADM1 and CD7 in CD4+ T cells are useful for separating HTLV-1\u2013uninfected T cells and ATL cells. They are indicators of clonal evolution of HTLV-1\u2013infected cells and disease progression of asymptomatic carriers or indolent ATL. However, the impacts of the plots on the clinical course or prognosis of ATL, especially in aggressive ATL, remain unclear. We focused on the N fraction (CD4+ CADM1+ CD7\u2013) reflecting ATL cells and analyzed the flow cytometric profiles and clinical course of 497 samples from 92 HTLV-1\u2013infected patients who were mainly aggressive ATL. The parameters based on N fractions showed significant correlations with known indicators of ATL disease status (soluble interleukin-2 receptor, lactate dehydrogenase, abnormal lymphocytes, etc.) and sensitively reflected the treatment response of aggressive ATL. The parameters based on N fractions significantly stratified the prognosis of aggressive ATL at 4 different time points: before treatment, after 1 course of chemotherapy, at the best response after chemotherapy, and before allogeneic hematopoietic cell transplantation. Even after mogamulizumab administration, which shows potent effects for peripheral blood lesions, the N fraction was still a useful indicator for prognostic estimation. In summary, this report\u00a0shows that CADM1 vs CD7 plots in CD4+ T cells are useful indicators of the clinical course and prognosis of aggressive ATL. Therefore, this CADM1 and CD7 profile is suggested\u00a0to be a useful prognostic indicator consistently from HTLV-1 carriers to aggressive ATL.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024013089","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T19:54:42Z","timestamp":1717185282000},"page":"3760-3770","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":12,"title":["Flow cytometric profiles with CD7 and CADM1 in CD4+ T cells are promising indicators for prognosis of aggressive ATL"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2031-7385","authenticated-orcid":false,"given":"Koji","family":"Jimbo","sequence":"first","affiliation":[{"name":"1Department of Hematology\/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1311-8756","authenticated-orcid":false,"given":"Toyotaka","family":"Kawamata","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4881-0427","authenticated-orcid":false,"given":"Yoshihiro","family":"Inamoto","sequence":"additional","affiliation":[{"name":"3Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Ito","sequence":"additional","affiliation":[{"name":"3Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2556-3833","authenticated-orcid":false,"given":"Kazuaki","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"1Department of Hematology\/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1714-1347","authenticated-orcid":false,"given":"Aki","family":"Sato","sequence":"additional","affiliation":[{"name":"1Department of Hematology\/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[{"name":"3Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Uchimaru","sequence":"additional","affiliation":[{"name":"1Department of Hematology\/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan"},{"name":"4Laboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6526-0992","authenticated-orcid":false,"given":"Yasuhito","family":"Nannya","sequence":"additional","affiliation":[{"name":"1Department of Hematology\/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"issue":"3","key":"2024072313113939200_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"issue":"6","key":"2024072313113939200_bib2","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024072313113939200_bib3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front Microbiol"},{"key":"2024072313113939200_bib4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fmicb.2012.00322","article-title":"Adult T-cell leukemia: a review of epidemiological evidence","volume":"3","author":"Iwanaga","year":"2012","journal-title":"Front Microbiol"},{"issue":"3","key":"2024072313113939200_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"issue":"8","key":"2024072313113939200_bib6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised adult T-cell leukemia-Lymphoma International Consensus Meeting Report","volume":"37","author":"Cook","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"2024072313113939200_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/blood.2019004045","article-title":"How I treat adult T-cell leukemia\/lymphoma","volume":"137","author":"Cook","year":"2021","journal-title":"Blood"},{"issue":"14","key":"2024072313113939200_bib8","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1200\/JCO.2011.38.2101","article-title":"Prognostic index for acute- and lymphoma-type adult T-cell leukemia\/lymphoma","volume":"30","author":"Katsuya","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"2024072313113939200_bib9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/bjh.12962","article-title":"Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A)","volume":"166","author":"Fukushima","year":"2014","journal-title":"Br J Haematol"},{"issue":"7","key":"2024072313113939200_bib10","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3324\/haematol.2017.164996","article-title":"Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation","volume":"102","author":"Fuji","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"2024072313113939200_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1182\/blood-2017-01-757542","article-title":"Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma","volume":"130","author":"Katsuya","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2024072313113939200_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2017-01-761874","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma","volume":"131","author":"Kataoka","year":"2018","journal-title":"Blood"},{"issue":"8","key":"2024072313113939200_bib13","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.3324\/haematol.2022.281510","article-title":"Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia\/lymphoma","volume":"108","author":"Kameda","year":"2023","journal-title":"Haematologica"},{"issue":"8","key":"2024072313113939200_bib14","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2012-03-414490","article-title":"Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study","volume":"120","author":"Ishida","year":"2012","journal-title":"Blood"},{"issue":"9","key":"2024072313113939200_bib15","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41409-018-0139-z","article-title":"Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia\/lymphoma","volume":"53","author":"Inoue","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2024072313113939200_bib16","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.bbmt.2014.12.020","article-title":"A\u00a0retrospective analysis of treatment outcomes in adult T cell leukemia\/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: a single-center experience","volume":"21","author":"Kawada","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2024072313113939200_bib17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.bbmt.2014.02.014","article-title":"High level of serum soluble interleukin-2 receptor at transplantation predicts poor outcome of allogeneic stem cell transplantation for adult T cell leukemia","volume":"20","author":"Shigematsu","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2024072313113939200_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10428194.2016.1187270","article-title":"Newly identified poor prognostic factors for adult T-cell leukemia-lymphoma treated with allogeneic hematopoietic stem cell transplantation","volume":"58","author":"Tokunaga","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"2024072313113939200_bib19","first-page":"220","article-title":"Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases","volume":"78","author":"Dik","year":"2020","journal-title":"Neth J Med"},{"issue":"3","key":"2024072313113939200_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/cbf.290020302","article-title":"Lactate dehydrogenase. Biochemistry and function of lactate dehydrogenase","volume":"2","author":"Markert","year":"1984","journal-title":"Cell Biochem Funct"},{"issue":"3","key":"2024072313113939200_bib21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an International Consensus Meeting","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"2024072313113939200_bib22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1309\/AJCPS1K0OHLJYWWV","article-title":"Minimal residual disease detection by flow cytometry in adult T-cell leukemia\/lymphoma","volume":"133","author":"Shao","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2024072313113939200_bib23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1349-7006.2010.01833.x","article-title":"Leukemic T cells are specifically enriched in a unique CD3(dim)CD7(low) subpopulation of CD4(+) T cells in acute-type adult T-cell leukemia","volume":"102","author":"Tian","year":"2011","journal-title":"Cancer Sci"},{"issue":"11","key":"2024072313113939200_bib24","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1158\/1078-0432.CCR-13-3169","article-title":"CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia\/lymphoma","volume":"20","author":"Kobayashi","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2024072313113939200_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/cclm-2014-0183","article-title":"Quantification of adult T-cell leukemia\/lymphoma cells using simple four-color flow cytometry","volume":"53","author":"Ishigaki","year":"2015","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"2024072313113939200_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41408-021-00458-8","article-title":"Quantification of T cell clonality in human T cell leukaemia virus type-1 carriers can detect the development of adult T cell leukaemia early","volume":"11","author":"Wolf","year":"2021","journal-title":"Blood Cancer J"},{"issue":"5","key":"2024072313113939200_bib27","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/cas.12639","article-title":"Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry","volume":"106","author":"Kobayashi","year":"2015","journal-title":"Cancer Sci"},{"issue":"12","key":"2024072313113939200_bib28","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1111\/cas.14219","article-title":"CD4(+)CADM1(+) cell percentage predicts disease progression in HTLV-1 carriers and indolent adult T-cell leukemia\/lymphoma","volume":"110","author":"Makiyama","year":"2019","journal-title":"Cancer Sci"},{"issue":"11","key":"2024072313113939200_bib29","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol"},{"issue":"3","key":"2024072313113939200_bib30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2024072313113939200_bib31","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bbmt.2008.03.010","article-title":"Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia\/lymphoma: impact of antithymocyte globulin on clinical outcome","volume":"14","author":"Tanosaki","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2024072313113939200_bib32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/bmt.2010.92","article-title":"Long-term outcomes after hematopoietic SCT for adult T-cell leukemia\/lymphoma: results of prospective trials","volume":"46","author":"Choi","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"2024072313113939200_bib33","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","article-title":"Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"2024072313113939200_bib34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult t-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"2024072313113939200_bib35","doi-asserted-by":"crossref","first-page":"e0135042","DOI":"10.1371\/journal.pone.0135042","article-title":"The impact of opportunistic infections on clinical outcome and healthcare resource uses for adult T cell leukaemia","volume":"10","author":"Maeda","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"2024072313113939200_bib36","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1038\/s41467-021-25101-9","article-title":"Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma","volume":"12","author":"Yamagishi","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"2024072313113939200_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41409-020-00996-y","article-title":"GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia\/lymphoma","volume":"56","author":"Muranushi","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"28","key":"2024072313113939200_bib38","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2016.67.8250","article-title":"Pretransplantation anti-CCR4 antibody mogamulizumab against adult T-cell leukemia\/lymphoma is associated with significantly increased risks of severe and corticosteroid-refractory graft-versus-host disease, nonrelapse mortality, and overall mortality","volume":"34","author":"Fuji","year":"2016","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/14\/3760\/2235664\/blooda_adv-2024-013089-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/14\/3760\/2235664\/blooda_adv-2024-013089-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T13:45:03Z","timestamp":1721742303000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/14\/3760\/516343\/Flow-cytometric-profiles-with-CD7-and-CADM1-in-CD4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":38,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024013089","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]}}}